The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2

[1]  Liuping Zhang,et al.  The synergistic antifungal effects of sodium phenylbutyrate combined with azoles against Candida albicans via the regulation of the Ras-cAMP-PKA signalling pathway and virulence. , 2019, Canadian journal of microbiology.

[2]  Guanghua Huang,et al.  Global regulatory roles of the cAMP/PKA pathway revealed by phenotypic, transcriptomic and phosphoproteomic analyses in a null mutant of the PKA catalytic subunit in Candida albicans , 2017, Molecular microbiology.

[3]  H. Bujdáková,et al.  Properties and role of the quorum sensing molecule farnesol in relation to the yeast Candida albicans. , 2017, Die Pharmazie.

[4]  Xin Wei,et al.  In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains , 2017, Biofouling.

[5]  L. Cowen,et al.  Staurosporine Induces Filamentation in the Human Fungal Pathogen Candida albicans via Signaling through Cyr1 and Protein Kinase A , 2017, mSphere.

[6]  L. Bernier,et al.  From yeast to hypha: defining transcriptomic signatures of the morphological switch in the dimorphic fungal pathogen Ophiostoma novo-ulmi , 2016, BMC Genomics.

[7]  S. Brunke,et al.  Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation , 2016, Front. Microbiol..

[8]  M. Ansari,et al.  Antifungal Action of Methylene Blue Involves Mitochondrial Dysfunction and Disruption of Redox and Membrane Homeostasis in C. albicans , 2016, The open microbiology journal.

[9]  R. Rajendran,et al.  Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection—Scotland, 2012–2013 , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  Elizabeth L. Alexander,et al.  In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. , 2015, The Journal of antimicrobial chemotherapy.

[11]  J. Ernst,et al.  Morphogenesis-regulated localization of protein kinase A to genomic sites in Candida albicans , 2013, BMC Genomics.

[12]  D. Hogan,et al.  Farnesol and Cyclic AMP Signaling Effects on the Hypha-to-Yeast Transition in Candida albicans , 2012, Eukaryotic Cell.

[13]  F. Mühlschlegel,et al.  Functional Characterization of the Small Heat Shock Protein Hsp12p from Candida albicans , 2012, PloS one.

[14]  Z. Sekawi,et al.  Comparative Characterisation of Genotypically Different Clones of MRSA in the Production of Biofilms , 2012, Journal of biomedicine & biotechnology.

[15]  D. Hogan,et al.  Candida albicans developmental regulation: adenylyl cyclase as a coincidence detector of parallel signals. , 2011, Current opinion in microbiology.

[16]  Li-hua Yu,et al.  Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm , 2011, Antimicrobial Agents and Chemotherapy.

[17]  Haishan Wang,et al.  Characterization of a hyperactive Cyr1 mutant reveals new regulatory mechanisms for cellular cAMP levels in Candida albicans , 2011, Molecular microbiology.

[18]  L. Levin,et al.  The Quorum-Sensing Molecules Farnesol/Homoserine Lactone and Dodecanol Operate via Distinct Modes of Action in Candida albicans , 2011, Eukaryotic Cell.

[19]  Bor-Sen Chen,et al.  Global screening of potential Candida albicans biofilm-related transcription factors via network comparison , 2010, BMC Bioinformatics.

[20]  Aimee K. Zaas,et al.  Hsp90 Governs Echinocandin Resistance in the Pathogenic Yeast Candida albicans via Calcineurin , 2009, PLoS pathogens.

[21]  L. Stateva,et al.  Farnesol and dodecanol effects on the Candida albicans Ras1‐cAMP signalling pathway and the regulation of morphogenesis , 2007, Molecular microbiology.

[22]  Katarzyna Piekarska,et al.  Deletion of the high‐affinity cAMP phosphodiesterase encoded by PDE2 affects stress responses and virulence in Candida albicans , 2007, Molecular microbiology.

[23]  D. Andes,et al.  Beta -1,3 glucan as a test for central venous catheter biofilm infection. , 2007, The Journal of infectious diseases.

[24]  U. Krings,et al.  A Comparison of Cell Wall Disruption Techniques for the Isolation of Intracellular Metabolites from Pleurotus and Lepista sp. , 2006, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[25]  L. Stateva,et al.  Deletion of PDE2, the gene encoding the high‐affinity cAMP phosphodiesterase, results in changes of the cell wall and membrane in Candida albicans , 2005, Yeast.

[26]  Jong-In Park,et al.  The high-affinity cAMP phosphodiesterase of Saccharomyces cerevisiae is the major determinant of cAMP levels in stationary phase: involvement of different branches of the Ras-cyclic AMP pathway in stress responses. , 2005, Biochemical and biophysical research communications.

[27]  K. Ying,et al.  cDNA Microarray Analysis of Differential Gene Expression in Candida albicans Biofilm Exposed to Farnesol , 2005, Antimicrobial Agents and Chemotherapy.

[28]  R. Kolter,et al.  The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. , 2004, Gene.

[29]  T. Edlind,et al.  Cyclic AMP Signaling Pathway Modulates Susceptibility of Candida Species and Saccharomyces cerevisiae to Antifungal Azoles and Other Sterol Biosynthesis Inhibitors , 2003, Antimicrobial Agents and Chemotherapy.

[30]  Y. Bahn,et al.  Increased high‐affinity phosphodiesterase PDE2 gene expression in germ tubes counteracts CAP1‐dependent synthesis of cyclic AMP, limits hypha production and promotes virulence of Candida albicans , 2003, Molecular microbiology.

[31]  L. Stateva,et al.  The cAMP phosphodiesterase encoded by CaPDE2 is required for hyphal development in Candida albicans. , 2003, Microbiology.

[32]  B. Wickes,et al.  Inhibition of Candida albicans Biofilm Formation by Farnesol, a Quorum-Sensing Molecule , 2002, Applied and Environmental Microbiology.

[33]  M. Ghannoum,et al.  Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins , 2002, Antimicrobial Agents and Chemotherapy.

[34]  H. Liu,et al.  Transcriptional control of dimorphism in Candida albicans. , 2001, Current opinion in microbiology.

[35]  D. Dignard,et al.  Ras links cellular morphogenesis to virulence by regulation of the MAP kinase and cAMP signalling pathways in the pathogenic fungus Candida albicans , 2001, Molecular microbiology.

[36]  R. Donlan.  Biofilm formation: a clinically relevant microbiological process. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  Mahmoud A. Ghannoum,et al.  Biofilm Formation by the Fungal PathogenCandida albicans: Development, Architecture, and Drug Resistance , 2001, Journal of bacteriology.

[38]  P. Sudbery,et al.  The MET3 promoter: a new tool for Candida albicans molecular genetics , 1999, Molecular microbiology.

[39]  H. Kumagai,et al.  Gpr1p, a putative G-protein coupled receptor, regulates glucose-dependent cellular cAMP level in yeast Saccharomyces cerevisiae. , 1998, Biochemical and biophysical research communications.

[40]  G. Gadd,et al.  Effect of nucleosides and nucleotides and the relationship between cellular adenosine 3′∶5′-cyclic monophosphate (cyclic AMP) and germ tube formation in Candida albicans , 1992, Mycopathologia.

[41]  Liuping Zhang,et al.  The synergistic antifungal effects of sodium phenylbutyrate combined with azoles against Candida albicans via regulating Ras/cAMP/PKA signalling pathway and virulence , 2018 .

[42]  R. Cordeiro,et al.  Minimum inhibitory concentrations of amphotericin B, azoles and caspofungin against Candida species are reduced by farnesol. , 2013, Medical mycology.